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METHODS
Western blotting
AK2 protein expression was detected by using a polyclonal antibody
(Proteintech, Chicago, Ill) using extracts from magnetically purified CD31 T
cells (STEMCELLTechnologies, Vancouver, British Columbia, Canada) and
fibroblast lines. Beta actin was detected by using a loading control kit (Cell
Signaling Technology, Beverly, Mass).
Assessment of maternal engraftment
DNA extracted from magnetically separated populations was subjected to
short tandem repeat analysis as previously described.E1 Flow-based analysis
was performed by using antibody to HLA-A2 (BB7.2, Biolegend, San Diego,
Calif), which distinguished the mother (HLA-A2, -A33) from the patient
(HLA-A23, -A33).
Assessment of T-cell receptor diversity
Percentage of expression of TCRVb families in CD31, CD41, and CD81
cells was detected by using specific mAbs for 24 families according to
the manufacturer’s specifications (Beckman Coulter, Brea, Calif) and
counterstaining with fluorochrome-conjugated antibodies to CD3 (UCHT1),
CD4 (OKT4), and CD8a (SK1) (Biolegend, San Diego, Calif).
Disruption of mitochondrial membrane potential in
T lymphocytes
CD31 T cells positively selected from Ficoll-purified PBMC using anti-
CD31–conjugated magnetic beads (Miltenyi Biotec, Cambridge, Mass) were
incubated at 378C in 5% CO2 in complete RPMI medium (4% FCS, 100 unit/
mL penicillin, 100 ug/mL streptomycin, and 2 mM L-glutamine) with or with-
out 6 uM staurosporin (Sigma-Aldrich, St Louis, Mo) for 3, 6, and 9 hours. Mi-
toPT TMRE dye (ICT945 AbD Serotec) 150 nM was added during the last 20
minutes of culture, and intracellular TMRE staining and CD3 surface
expression were detected by using FACS Calibur (BD Biosciences, San Jose,
Calif). Data was analyzed by using FlowJo software (Treestar, Ashland, Ore).
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FIG E1. Patient exhibited desquamative erythroderma.
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FIG E2. Analysis using genomic DNA from fibroblasts and CD31 lymphocytes demonstrating a missense
mutation in AK2 (c.524 G>A, p.R175Q).
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